These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Epidemiology and Mechanisms of De Novo and Persistent Hypertension in the Postpartum Period. Goel A; Maski MR; Bajracharya S; Wenger JB; Zhang D; Salahuddin S; Shahul SS; Thadhani R; Seely EW; Karumanchi SA; Rana S Circulation; 2015 Nov; 132(18):1726-33. PubMed ID: 26416810 [TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetics of amlodipine besylate at delivery and during lactation. Morgan JL; Kogutt BK; Meek C; Stehel EK; McIntire DD; Sheffield JS; Roberts SW Pregnancy Hypertens; 2018 Jan; 11():77-80. PubMed ID: 29523279 [TBL] [Abstract][Full Text] [Related]
44. Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review. Brewster LM; Seedat YK BMC Med; 2013 May; 11():141. PubMed ID: 23721258 [TBL] [Abstract][Full Text] [Related]
45. Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. Reboldi G; Gentile G; Angeli F; Verdecchia P Vasc Health Risk Manag; 2009; 5(1):411-27. PubMed ID: 19475778 [TBL] [Abstract][Full Text] [Related]
46. Plasma renin activity (PRA) levels and antihypertensive drug use in a large healthcare system. Sim JJ; Bhandari SK; Shi J; Kalantar-Zadeh K; Rasgon SA; Sealey JE; Laragh JH Am J Hypertens; 2012 Mar; 25(3):379-88. PubMed ID: 22158065 [TBL] [Abstract][Full Text] [Related]
47. Recent advances in drugs against hypertension. Neelima ; Bhat BK; Bhaduri AP Prog Drug Res; 1985; 29():215-76. PubMed ID: 2868487 [No Abstract] [Full Text] [Related]
48. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325 [TBL] [Abstract][Full Text] [Related]
49. Update in pharmacologic treatment of hypertension. Ferdinand KC Cardiol Clin; 2001 May; 19(2):279-94, v. PubMed ID: 11407110 [TBL] [Abstract][Full Text] [Related]
50. Rationale for angiotensin II receptor blockers in patients with low-renin hypertension. Jamerson KA Am J Kidney Dis; 2000 Sep; 36(3 Suppl 1):S24-30. PubMed ID: 10986156 [TBL] [Abstract][Full Text] [Related]
51. National recommendations for the pharmacological treatment of hypertension: should they be revised? Moser M Arch Intern Med; 1999 Jul; 159(13):1403-6. PubMed ID: 10399891 [No Abstract] [Full Text] [Related]
54. Pressor responses to antihypertensive drug types. Alderman MH; Cohen HW; Sealey JE; Laragh JH Am J Hypertens; 2010 Sep; 23(9):1031-7. PubMed ID: 20725055 [TBL] [Abstract][Full Text] [Related]
55. Cardiovascular outcomes and antihypertensive drug treatment in older women. Staessen JA; Thijs L; Wang J; Li Y JAMA; 2005 Apr; 293(13):1588; author reply 1588-9. PubMed ID: 15811972 [No Abstract] [Full Text] [Related]
56. Cardiovascular outcomes and antihypertensive drug treatment in older women. Bursztyn M JAMA; 2005 Apr; 293(13):1588; author reply 1588-9. PubMed ID: 15811971 [No Abstract] [Full Text] [Related]
57. Approach to Antihypertensive Therapy. Reddy P; Dupree L Am J Ther; 2016; 23(2):e451-73. PubMed ID: 25719531 [TBL] [Abstract][Full Text] [Related]
58. How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis. Bradley HA; Wiysonge CS; Volmink JA; Mayosi BM; Opie LH J Hypertens; 2006 Nov; 24(11):2131-41. PubMed ID: 17053529 [TBL] [Abstract][Full Text] [Related]